KRISTIN JUNEK: Open Payments
NPI 1669944617 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 13 payments from 10 companies in 2025. Trend: 2023 $1,650 · 2024 $1,279 · 2025 $1,464
Food & beverage: $1,375Education: $85Speaker / faculty: $4
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 2 | $250 |
| Ascendis Pharma Endocrinology Inc | 2 | $234 |
| Daiichi Sankyo Inc. | 2 | $153 |
| Janssen Scientific Affairs, LLC | 1 | $148 |
| Deciphera Pharmaceuticals Inc. | 1 | $143 |
| Kite Pharma, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| Organon LLC | 1 | $102 |
| Janssen Biotech, Inc. | 1 | $85 |
Products named: ZENPEP, Yorvipath, TREMFYA, Enhertu, QINLOCK, Yescarta, IMFINZI, RECORLEV.
Industry payments across TX — which companies pay providers there.
